NinePointTwo Capital’s AbbVie ABBV Stock Holding History

NinePointTwo Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$615K	Hold	3,970	–	–	0.24%	32
2023 Q3	$591K	Hold	3,970	–	–	0.24%	27
2023 Q2	$534K	Hold	3,970	–	–	0.21%	30
2023 Q1	$632K	Sell	3,970 -76	-2%	-$11.6K	0.24%	26
2022 Q4	$653K	Hold	4,046	–	–	0.27%	22
2022 Q3	$543K	Hold	4,046	–	–	0.22%	26
2022 Q2	$619K	Buy	4,046 +76	+2%	+$11.6K	0.22%	25
2022 Q1	$643K	Hold	3,970	–	–	0.17%	29
2021 Q4	$537K	Hold	3,970	–	–	0.17%	30
2021 Q3	$428K	Hold	3,970	–	–	0.17%	29
2021 Q2	$447K	Hold	3,970	–	–	0.16%	37
2021 Q1	$429K	Buy	3,970 +441	+12%	+$47.2K	0.16%	37
2020 Q4	$378K	Buy	+3,529	New	+$339K	0.15%	39

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NinePointTwo Capital's ABBV Position: Q4 2023 in Review

NinePointTwo Capital held its AbbVie (ABBV) position steady in Q4 2023 at 3,970 shares worth $615K. The position accounts for 0.24% of the portfolio, ranked #32.

NinePointTwo Capital first reported a position in ABBV in Q4 2020 and has held it in 13 quarters since. The position peaked at $653K in Q4 2022. 3,322 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

NinePointTwo Capital held 3,970 shares of AbbVie worth $615K as of Q4 2023.
NinePointTwo Capital left its AbbVie share count unchanged in Q4 2023.
AbbVie made up 0.24% of NinePointTwo Capital's portfolio in Q4 2023, its #32 holding.
NinePointTwo Capital first reported a position in AbbVie in Q4 2020 and has held it in 13 quarters since.
NinePointTwo Capital's AbbVie position peaked at $653K in Q4 2022.
3,322 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.